Viopro Report issue

For profit Phase 3
Founded: San Jose CA United States (1982)
Status: No NME R&D (1982)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

Key: Viopro (0) Acquired (1)

belagenpumatucel-l (3 trials)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 3
  • # of Trial APIs: 1